Description

9-(β-D-Ribofuranosylmethyl)-9H-Purine-6-Amine CAS NO 29868-39-1 is a specialized nucleoside analogue of significant interest in advanced pharmaceutical research and development. This compound serves as a crucial building block for the synthesis of novel antiviral and anticancer agents, offering researchers a versatile scaffold for molecular modification. It is primarily utilized by pharmaceutical R&D laboratories, biotechnology companies, and academic institutions engaged in medicinal chemistry and drug discovery programs.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of novel nucleoside-based antiviral and anticancer drug candidates.
• Medicinal Chemistry Research: Essential building block for structure-activity relationship (SAR) studies and the development of purine nucleoside analogues.
• Biochemical Research: Used as a substrate or inhibitor in enzymatic studies involving nucleoside metabolism and related pathways.
• Antiviral Agent Development: Investigated for its potential activity and as a core structure for compounds targeting viral polymerases.
• Oncology Research: Serves as a starting material for creating potential chemotherapeutic agents that interfere with DNA/RNA synthesis.
• Reference Standard: Employed as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.

Basic Information

Product Name	9-(β-D-Ribofuranosylmethyl)-9H-Purine-6-Amine
CAS No.	29868-39-1
Molecular Formula	C11H15N5O4
Molecular Weight	281.27 g/mol
Synonyms	6-Amino-9-(β-D-ribofuranosylmethyl)-9H-purine; 9-(β-D-Ribofuranosylmethyl)adenine; 9-(β-D-Ribofuranosylmethyl)purin-6-amine; 9-(β-D-Ribofuranosylmethyl)-9H-purin-6-amine; 9-(β-D-Ribofuranosylmethyl)adenine; N6-Amino-9-(β-D-ribofuranosylmethyl)purine; Adenine, 9-(β-D-ribofuranosylmethyl)-; 9-(β-D-Ribofuranosylmethyl)adenine (Aristeromycin precursor analogue)
EINECS	Contact for details

Quality Control

Our 9-(β-D-Ribofuranosylmethyl)-9H-Purine-6-Amine is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity suitable for research applications. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles, typically determined by advanced analytical techniques such as HPLC, NMR, and mass spectrometry. We are committed to meeting the stringent requirements of pharmaceutical R&D.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Related Substances (HPLC)	Individual impurity ≤ 0.5%; Total impurities ≤ 1.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.